Clinical Trials Directory

Trials / Completed

CompletedNCT03516565

Matrix Metalloproteinases's in Oral Biofluids During Pregnancy and Postpartum

Modulation of Matrix Metalloproteinases-8, -9 and Endogenous Tissue Inhibitor-1 in Oral Biofluids During Pregnancy and Postpartum

Status
Completed
Phase
Study type
Observational
Enrollment
114 (actual)
Sponsor
Aydin Adnan Menderes University · Academic / Other
Sex
Female
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

The aim of this study was to investigate salivary and gingival crevicular fluid (GCF) levels of MMP-8, MMP-9 and TIMP-1 during 2/3 trimester of pregnancy and after delivery

Detailed description

MMP-8 and MMP-9 have been reported to reflect the inflammatory status in periodontal tissues and, therefore represent as potential biomarkers of periodontitis. The balance between tissue inhibitors of metalloproteinases (TIMPs) and MMPs play an important role in maintaining the integrity of healthy periodontium.

Conditions

Interventions

TypeNameDescription
OTHERSaliva collection
OTHERGCF collection

Timeline

Start date
2013-04-01
Primary completion
2014-10-15
Completion
2015-09-01
First posted
2018-05-04
Last updated
2018-05-04

Source: ClinicalTrials.gov record NCT03516565. Inclusion in this directory is not an endorsement.

Matrix Metalloproteinases's in Oral Biofluids During Pregnancy and Postpartum (NCT03516565) · Clinical Trials Directory